Cardiovascular Diseases
Cardiovascular Diseases
11/07/2019
The STURDY study recently evaluated how OH timing is associated with dizziness in older patients. Coauthor Stephen P. Juraschek, MD, PhD, discusses these findings and how they compare with past...
11/07/2019
Antihypertensives
Antihypertensives
10/30/2019
In this editorial by Consultant Board Member Dr Michael Bloch, he reflects on a 1961 Consultant article about cardiovascular disease management and how it has affected him.
10/30/2019
Antibiotics
Antibiotics
09/12/2019
A recent study highlighted a link between the use of fluoroquinolones, a commonly prescribed class of antibiotic, and the risk of aortic and mitral regurgitation. Consultant360 spoke with Mahyar Etminan,...
09/12/2019
Cardiovascular Diseases
Cardiovascular Diseases
08/21/2019
Stephen Kopecky, MD, from Mayo Clinic, talks about nonpharmacologic and pharmacologic options for preventing atrial fibrillation.
08/21/2019
Cardiometabolic risk
Cardiometabolic risk
08/08/2019
Yehuda Handelsman, MD, writes about the importance of managing lipids in patients with diabetes and CVD, how hyperglycemia affects the body, and more.
08/08/2019
Cardiovascular Diseases
Cardiovascular Diseases
07/24/2019
Dr Cohen discusses the strengths and weaknesses of current BP measurements.
07/24/2019
Cardiovascular Diseases
Cardiovascular Diseases
06/12/2019
In this podcast, Zubin Modi, MD, from the University of Michigan Medical School, discusses his research on the risk of CVD in young adults with end-stage renal disease.
06/12/2019
Pitfalls In Prescribing
Pitfalls In Prescribing
05/28/2019
Timothy H. Self, PharmD; Samantha Ellingson, PharmD, BCPS
When considering potential drug interactions with statin therapy, it is important to consider the hepatic pathways that could be negatively impacted with the addition of new medications.
05/28/2019
Cardiovascular Diseases
Cardiovascular Diseases
05/24/2019
William E. Boden, MD, discusses his research in which he and his colleagues tried to replicate the results seen in the REDUCE-IT trial. His research was also presented at ACC.19 Scientific Session.
05/24/2019
Cholesterol
Cholesterol
05/15/2019
In this commentary, Robert Rosenson, MD, explains that PCSK9 inhibitors may be a useful alternative therapy in lowering LDL cholesterol in individuals who are unable to tolerate statins at the doses...
05/15/2019